Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Spotlight
GLP-1s
Interviews
FDA
Strategy
Generics
Biosimilars
Value Added Medicines
Business
Deals
Earnings
Manufacturing
Policy & Regulation
Regulatory Landscape
Drug Pricing
IP & Litigation
Tools & Trackers
What's Next?
Who's Hired?
UK Pricing Tracker
Company Rankings
Podcasts
Conference Coverage
Partner Insights
Generics Bulletin Perspectives
Exploring market-shifting topics for the off-patent sector.
View
Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Lupin Cuts Forecast Despite Etanercept Launch
Firm Sees Trump 'Buy American' Order As Near-Term Opportunity
Aug 13 2020
•
By
Vibha Ravi
Lupin's First Quarter Performance Guides Lower FY21 Forecast • Source: Shutterstock
More from Earnings
More from Business
